Specific issues related to FMD surveillance in the eastern Africa sub-region. Gideon Brückner

Similar documents
Foot and mouth disease situation and control strategies in sub-saharan Africa the current situation

AIDS in Africa. An Update. Basil Reekie

Appendix 22. Vosloo, W. 1*, Dwarka, R.M. 1, Bastos, A.D.S. 2, Esterhuysen, J.J. 1, Sahle, M. 3, Sangare, O. 4

Scaling Up Nutrition Action for Africa

Annex 2 A. Regional profile: West Africa

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

What is this document and who is it for?

World Organisation for Animal Health Protecting animals, Preserving our future 1

Rift Valley Fever. What is Rift Valley Fever?

IMMUNIZATION & VACCINE PREVENTABLE DISEASES

Title of the presentation: The FMD virus. Subtitle: Virus Pool 6, Southern Africa. pools and Regional programs. Name Surname: Misheck Mulumba et al

IMMUNIZATION VACCINES & EMERGENCIES

Elements of the FMD control problem in Southern Africa: 2

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report

UNAIDS 2013 AIDS by the numbers

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN

Foot-and-Mouth Disease situation Food and Agriculture Organization of the United Nations Monthly Report

IMMUNIZATION VACCINE DEVELOPMENT

Impact of Pathology Implementation Strategies in Sub Saharan Africa

Contagious bovine pleuropneumonia (lungsickness)

GABON. Neglected tropical disease treatment report profile for mass treatment of NTDs

Appendix 5. The challenge. Virus pools and Regional Roadmaps. The Progressive Control Pathway PCP) for FMD control PCP-FMD

! Multisectoral Information, Data, Research & Evidence - for Health, Population, Human & Social Development!

Foot-and-Mouth Disease situation Food and Agriculture Organization of the United Nations Monthly Report

Africa s slow fertility transition

ASLM Anti-microbial Resistance in Africa and Global Health Security. 9TH INTEREST WORKSHOP May 2015 Harare

Prioritizing Emergency Polio Eradication Activities

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY

FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat

ASLM Building laboratory capacity in Africa in a sustainable way

1) SO1: We would like to suggest that the indicator used to measure vaccine hesitancy be DTP 1 to measles first dose dropout.

Unique features of foot and mouth disease in Southern Africa

Foot-and-Mouth Disease Situation Monthly Report MARCH EuFMD

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

Influenza Surveillance In the WHO African Region

Global reductions in measles mortality and the risk of measles resurgence

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

Eligibility List 2018

Excellence and Originality from Necessity: Palliative Care in Africa. Dr Emmanuel Luyirika Executive Director, African Palliative Care Association

Ouagadougou Declaration

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

TFI Proceedings, Recommendations and implications for 2005

( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI

THE CARE WE PROMISE FACTS AND FIGURES 2017

CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN

Comparative Analyses of Adolescent Nutrition Indicators

Demographic Transitions, Solidarity Networks and Inequality Among African Children: The Case of Child Survival? Vongai Kandiwa

Global summary of the AIDS epidemic, December 2007

Yellow fever Vaccine investment strategy

CREOLE Study: Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans. CREOLE Study

MEASLES ELIMINATION BY 2020: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat. Executive Summary

Children in Africa. Key statistics on child survival, protection and development

Regional Status and FMD s Control Strategies in North Africa

מדינת ישראל. Tourist Visa Table

Biosecurity, biobanking and data management during public health crises in Africa. A peer into the future.

Food Production and Violent Conflict in Sub-Saharan Africa. - Supplementary Information -

Gender, Poverty, and Health in Sub-Saharan Africa: A Framework for Analysis

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

THE FUTURE OF ADULT MORTALITY UNDER THE AIDS THREAT: ESTIMATING AND PROJECTING INCIDENCE; PROJECTING MORTALITY WITH HIV/AIDS *

AFRICA. The continent of All challenges

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

Global Polio Eradication Initiative

Expert Paper No. 2011/13

Overview of WHO/UNICEF Immunization Coverage Estimates

Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region. Dr Zabulon Yo, & Dr Anthony Stewart

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control

Ageing and mental health resources for older persons in the African region of the World Health Organization

Incorporating combination polypharmacy into national or provincial CVD control strategies: An African perspective

Age-Sex Structure for Selected African countries in the early 2000s

CANCER OF THE CERVIX IN THE AFRICAN REGION: CURRENT SITUATION AND WAY FORWARD

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

Progress has been made with respect to health conditions.

What is the recent experience of programs that distribute contraceptives free of charge versus for a price?

Plan of Presentation

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

Medicines Regulation, Regulatory Harmonization, Global Initiatives. Tonya Villafana, PhD, MPH Senior Health Specialist, World Bank

Using routine data to estimate numbers of women with female genital mutilation / cutting in European countries

Okwen PM 1,2, Maweu IW 1,3, Ndimbum CN 1, Evina Danielle 2 Ongolo-Zogo Pierre 2, George Nel 4, Anastase Dzudzie 4, Dike Orji 4, Mayosi Bongani 4

Wild Poliovirus Weekly Update

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

Global Fund Results Fact Sheet Mid-2011

Global Fund ARV Fact Sheet 1 st June, 2009

Fertility and Family Planning in Africa: Call for Greater Equity Consciousness

PPR in Asia. History and Distribution PPR DISTRIBUTION PPR DISTRIBUTION PPR DISTRIBUTION Zhiliang Wang Prof. Dr.

Blood safety in Africa: Progress made during the last decade and major challenges for the Future

This also applies to all travellers transiting through countries with risk of transmission of yellow fever.

Dr Ghazi Yehia OIE Regional Representative for the Middle East

FMD Situation in Europe and other Regions 2000

Tipping the dependency

SGCEP SCIE 1121 Environmental Science Spring 2012 Section Steve Thompson:

Towards an Atlas of Human Helminth Infection in sub-saharan Africa: The Use of Geographical Information Systems (GIS)

COMBATING MICRONUTRIENT MALNUTRITION IN AFRICA WITH FLOUR FORTIFICATION: CURRENT STATUS AND CHALLENGES

Measles Supplementary Immunization Activities and GAVI Funds as Catalysts for Improving Injection Safety in Africa

Foot and Mouth Disease Middle East situation Summary of Answers to the Questionnaire Beirut, Lebanon, 7 9 April 2009

Transcription:

Specific issues related to FMD surveillance in the eastern Africa sub-region Gideon Brückner 1

Why do we do surveillance for FMD? Demonstrating freedom from FMD, FMDV infection and/or FMDV transmission Early detection and investigation of cases Demonstrating the effectiveness of vaccination, if practised Contingency planning Reaction to alerts 2

Critical underlying rationale of surveillance To demonstrate freedom from infection veterinary services have to search actively for any evidence of its presence and exclude it The search for infection(s) is one of the main routine tasks of the veterinary services and is performed using a number of approaches and strategies The only difference between countries practicing and not practicing vaccination is that: in the absence of vaccination the presence of infected animals will eventually lead to virus spread, which makes virtually impossible not to detect the presence of the infection in massively vaccinated populations the presence of a single or a few infected animals might not result in virus circulation and the infection might either be undetected or die off naturally Acknowledgement: V Caporale 3

Challenges in Eastern Africa that affects surveillance for FMD Buffalo carrier Borders between countries Movement of animals Drought conditions Transfrontier Conservation areas Ruralisation of the urban environment Dipping system of surveillance Role of small stock Only 5/15 SADC countries in Africa have achieved OIE status for FMD 4

General observations on FMD surveillance in Eastern Africa Usually well conducted when applying for freedom or endorsement of program Surveillance for maintenance of status less strict risk-based borders, threat When events affecting surveillance prevails lack of contingency plan (droughts, floods, other disease outbreaks) Reactions to alerts (risk of border intrusions) often too slow Role of small stock under-estimated Time-line for risk-based surveillance e.g. calving period of buffalo Reliance on vaccination as a buffer vs surveillance in adjoining non-vaccinated areas 5

Follow-up surveillance and role of NSP tests NSP tests reflects what might have happened in terms of viral circulation in preceding months Probang tests only reflects current situation is there active virus circulation? only 50% sensitive Negative probang in follow-up only demonstrates no active viral excretion present not if there was an event of viral transmission Need to incorporate total epidemiological and riskbased picture in follow-up operations Need to go back to same herd and same animals and in-contact herds and animals 6

Importance of post-vaccination monitoring tests Not strictly or routinely applied by all countries An important tool to monitor vaccination efficiency An important tool to monitor vaccine efficiency An important tool to monitor duration of vaccine immunity 7

Control actions in Africa Endemic countries No actions Limited vaccination Limited movement control Free countries Zoning Vaccination (routine and emergency) Movement control (permits, fencing) Stamping out Acknowledgement: W. Vosloo 8

Role of African buffalo in the epidemiology of FMD The 3 SAT serotypes are maintained by African buffalo (Syncerus caffer) that can be a source of infection for susceptible livestock in close proximity Buffalo can maintain FMDV for up to 5 years in a single animal FMD viruses change during persistent infection and may give rise to new antigenic variants Acknowledgement: W. Vosloo 9

Role of other wildlife species in FMD persistence and spread Species/animal Duration of viral persistence Domestic animals: Cattle Sheep Goats 2.5 to 3.5 years 9-12 months 2-3 months Wildlife: Wildebeest (Connochaetes taurinus) Sable (Hippotragus niger) Eland (Taurotragus oryx) Fallow deer (Dama dama) Kudu (Tragelaphus strepiceros) Water buffalo (Bubalis bubalis) African buffalo (Syncerus caffer) 28 days 28 days 32 days 63 days 104-160 days 2-24 months 5 years Acknowledgement: W. Vosloo 10

MORROCCO TUNISIA JORDAN ISRAEL ALGERIA LYBIA EGYPT SAUDI ARABIA MAURI TANIA GAMBIA SENEGAL MALI NIGER CHAD YEMEN GUINEA- BISAU SAT-2: SIERRA- LEONE Topotype I GUINEA LIBERIA COTE D IVOIRE BURKINA FASO GHANA B E N I N TOGO NIGERIA CAMEROON CENTRAL AFRICAN REPUBLIC SUDAN ERITREA ETHIOPIA Topotype II Topotype III Topotype IV EQUATORIAL GUINEA GABON CONGO ZAIRE UGANDA RWANDA BURUNDI KENYA SOMALIA Topotype V TANZANIA Topotype VI Topotype VII ANGOLA Topotype VIII ZAMBIA Topotype IX ZIMBABWE Topotype X Topotype XI NAMIBIA BOTSWANA Topotype XII Topotype XIII Topotype XIV SOUTH AFRICA LESOTHO SWAZILAND Acknowledgement: W. Vosloo 11

Potential impact on FMD control by Transfrontier Conservation Areas, wildlife The establishment of TFCAs Pressure to remove fences Human encroachment into wildlife areas Increased wildlife migration Introduction of novel FMD virus topotypes and impact on vaccines Wild animal migratory patterns Transhumance patterns Acknowledgement: W. Vosloo 12

Thank you for your attention! 13